Last Name

Kevin F. Ginn, MD

TitleNeuro-Oncologist and Director, Pediatric Brain Tumor Program
InstitutionChildren's Mercy Kansas City
Address2401 Gilham Rd
Kansas City MO 64108
vCardDownload vCard
    Other Positions
    TitleInterim Director, Experimental Therapeutics Program
    InstitutionChildren's Mercy Kansas City

    TitleAssistant Professor of Pediatrics
    InstitutionUniversity of Missouri-Kansas City

    TitleClinical Assistant Professor of Pediatrics
    InstitutionUniversity of Kansas Medical Center

    Collapse Biography 
    Collapse education and training
    Medical University of South Carolina College of Medicine, Charleston, SCMD2005
    Louisiana State University Health Sciences Center, Children's Hospital, New Orleans, LAResidency2008Pediatrics
    Children's Mercy Hospital, Kansas City, MOFellowship2011Pediatric Hematology/Oncology
    St. Jude Children's Research Hospital, Memphis, TNFellowship2012Pediatric Neuro-Oncology

    Collapse Overview 

    Collapse Research 
    Collapse research overview
    Dr. Ginn's clinical focus is in the care of pediatric patients with central nervous system tumors. He directs the multi-disciplinary team at Children's Mercy providing care for approximately 50 brain and spine cord tumors a year. His current primary research role is as Interim Director of the Experimental Therapeutics in Pediatric Oncology Program. Dr. Ginn is a site Principal Investigator for approximately 30 early phase clinical trials. His team participates in Children's Oncology Group, Beat Childhood Cancer, Aflac Cancer Center and Industry Sponsored clinical trials. They also provide support to local Oncologist regarding expanded access to investigational agents and provide support for local investigator initiated trials. He is interested in expanding collaborations and bringing more local investigator trials through to completion.

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lucas CG, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, Gener M, Ginn KF, Prall OWJ, Xu H, Kee D, Ko HS, Yaqoob N, Zia N, Florez A, Cha S, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA. EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. Acta Neuropathol. 2022 01; 143(1):109-113. PMID: 34825267.
      View in: PubMed
    2. Smith SC, Farooqi MS, Gener MA, Ginn K, Joyce JM, Bendorf TM, Cooley LD. Clinical Validation of Somatic Mutation Detection by the OncoScan CNV Plus Assay. J Mol Diagn. 2021 01; 23(1):29-37. PMID: 33080408.
      View in: PubMed
    3. Prince EW, Whelan R, Mirsky DM, Stence N, Staulcup S, Klimo P, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Limbrick DD, Smith A, Drapeau A, Chern JJ, Kilburn L, Ginn K, Naftel R, Dudley R, Tyler-Kabara E, Jallo G, Handler MH, Jones K, Donson AM, Foreman NK, Hankinson TC. Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images. Sci Rep. 2020 10 09; 10(1):16885. PMID: 33037266.
      View in: PubMed
    4. Prince E, Whelan R, Donson A, Staulcup S, Hengartner A, Vijmasi T, Agwu C, Lillehei KO, Foreman NK, Johnston JM, Massimi L, Anderson RCE, Souweidane MM, Naftel RP, Limbrick DD, Grant G, Niazi TN, Dudley R, Kilburn L, Jackson EM, Jallo GI, Ginn K, Smith A, Chern JJ, Lee A, Drapeau A, Krieger MD, Handler MH, Hankinson TC. Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets. Acta Neuropathol Commun. 2020 05 13; 8(1):68. PMID: 32404202.
      View in: PubMed
    5. Porath B, Farooki S, Gener M, Amudhavalli SM, Grote L, Cooley LD, Ginn K, Farooqi MS. Occurrence and characterization of medulloblastoma in a patient with Curry-Jones syndrome. Clin Genet. 2020 04; 97(4):670-671. PMID: 31825089.
      View in: PubMed
    6. Ginn KF, Fangman B, Terai K, Wise A, Ziazadeh D, Shah K, Gartrell R, Ricke B, Kimura K, Mathur S, Borrego-Diaz E, Farassati F. RalA is overactivated in medulloblastoma. J Neurooncol. 2016 10; 130(1):99-110. PMID: 27566179.
      View in: PubMed
    7. Butler DF, Ginn KF, Daniel JF, Bloomer JR, Kats A, Shreve N, Myers GD. Bone marrow transplant for X-linked protoporphyria with severe hepatic fibrosis. Pediatr Transplant. 2015 Jun; 19(4):E106-10. PMID: 25856424.
      View in: PubMed
    8. Zaky W, Dhall G, Khatua S, Brown RJ, Ginn KF, Gardner SL, Yildiz VO, Yankelevich M, Finlay JL. Choroid plexus carcinoma in children: the Head Start experience. Pediatr Blood Cancer. 2015 May; 62(5):784-9. PMID: 25662896.
      View in: PubMed
    9. Radhi M, Fulbright JM, Ginn KF, Guest EM. Childhood cancer for the primary care physician. Prim Care. 2015 Mar; 42(1):43-55. PMID: 25634704.
      View in: PubMed
    10. Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol. 2012; 2:114. PMID: 22988546.
      View in: PubMed
    Ginn's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description